BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28079433)

  • 1. PET imaging of cannabinoid type 2 receptors with [
    Pottier G; Gómez-Vallejo V; Padro D; Boisgard R; Dollé F; Llop J; Winkeler A; Martín A
    J Cereb Blood Flow Metab; 2017 Mar; 37(3):1163-1178. PubMed ID: 28079433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
    Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor.
    Slavik R; Herde AM; Bieri D; Weber M; Schibli R; Krämer SD; Ametamey SM; Mu L
    Eur J Med Chem; 2015 Mar; 92():554-64. PubMed ID: 25599952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2).
    Horti AG; Gao Y; Ravert HT; Finley P; Valentine H; Wong DF; Endres CJ; Savonenko AV; Dannals RF
    Bioorg Med Chem; 2010 Jul; 18(14):5202-7. PubMed ID: 20554448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Structure-Activity Relationships on Thiazole Derivatives to the In Vivo Evaluation of a New Radiotracer for Cannabinoid Subtype 2 PET Imaging.
    Caillé F; Cacheux F; Peyronneau MA; Jego B; Jaumain E; Pottier G; Ullmer C; Grether U; Winkeler A; Dollé F; Damont A; Kuhnast B
    Mol Pharm; 2017 Nov; 14(11):4064-4078. PubMed ID: 28968497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
    Mu L; Bieri D; Slavik R; Drandarov K; Müller A; Cermak S; Weber M; Schibli R; Krämer SD; Ametamey SM
    J Neurochem; 2013 Sep; 126(5):616-24. PubMed ID: 23795580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of [
    Attili B; Celen S; Ahamed M; Koole M; Haute CVD; Vanduffel W; Bormans G
    Br J Pharmacol; 2019 May; 176(10):1481-1491. PubMed ID: 30588600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study.
    Hosoya T; Fukumoto D; Kakiuchi T; Nishiyama S; Yamamoto S; Ohba H; Tsukada H; Ueki T; Sato K; Ouchi Y
    J Neuroinflammation; 2017 Mar; 14(1):69. PubMed ID: 28356120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of [
    Teodoro R; Gündel D; Deuther-Conrad W; Ueberham L; Toussaint M; Bormans G; Brust P; Moldovan RP
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation.
    Savonenko AV; Melnikova T; Wang Y; Ravert H; Gao Y; Koppel J; Lee D; Pletnikova O; Cho E; Sayyida N; Hiatt A; Troncoso J; Davies P; Dannals RF; Pomper MG; Horti AG
    PLoS One; 2015; 10(6):e0129618. PubMed ID: 26086915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
    Ahmad R; Postnov A; Bormans G; Versijpt J; Vandenbulcke M; Van Laere K
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2219-2227. PubMed ID: 27488857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.
    Chauveau F; Van Camp N; Dollé F; Kuhnast B; Hinnen F; Damont A; Boutin H; James M; Kassiou M; Tavitian B
    J Nucl Med; 2009 Mar; 50(3):468-76. PubMed ID: 19223401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system.
    Ni R; Mu L; Ametamey S
    Acta Pharmacol Sin; 2019 Mar; 40(3):351-357. PubMed ID: 29921889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI.
    Ni R; Müller Herde A; Haider A; Keller C; Louloudis G; Vaas M; Schibli R; Ametamey SM; Klohs J; Mu L
    Mol Imaging Biol; 2022 Oct; 24(5):700-709. PubMed ID: 34642898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain.
    Slavik R; Bieri D; Cermak S; Müller A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    Chimia (Aarau); 2014; 68(4):208-10. PubMed ID: 24983598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor.
    Slavik R; Grether U; Müller Herde A; Gobbi L; Fingerle J; Ullmer C; Krämer SD; Schibli R; Mu L; Ametamey SM
    J Med Chem; 2015 May; 58(10):4266-77. PubMed ID: 25950914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke.
    Chaney AM; Johnson EM; Cropper HC; James ML
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29985311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring neuroprotective effects using positron emission tomography with [11C]ITMM, a radiotracer for metabotropic glutamate 1 receptor.
    Yui J; Xie L; Fujinaga M; Yamasaki T; Hatori A; Kumata K; Nengaki N; Zhang MR
    Stroke; 2013 Sep; 44(9):2567-72. PubMed ID: 23908068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor.
    Moldovan RP; Teodoro R; Gao Y; Deuther-Conrad W; Kranz M; Wang Y; Kuwabara H; Nakano M; Valentine H; Fischer S; Pomper MG; Wong DF; Dannals RF; Brust P; Horti AG
    J Med Chem; 2016 Sep; 59(17):7840-55. PubMed ID: 27500461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.